SCHEMBL25013469

SCHEMBL25013469

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(C(=O)CN4CCN(C)CC4)ccc3OCC)nc12

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.85
PDE6C P51160 3/20 0.85
PDE3B Q13370 3/20 0.68
PDE3A Q14432 3/20 0.68
PDE1A P54750 2/20 0.68
PDE1B Q01064 2/20 0.68
PDE1C Q14123 2/20 0.68
ABCC4 O15439 2/20 0.68
PDE2A O00408 1/20 0.68
ABCC5 O15440 1/20 0.68
PDE6D O43924 1/20 0.68
PDE8A O60658 1/20 0.68
PDE9A O76083 1/20 0.68
ABCB11 O95342 1/20 0.68
CYP3A4 P08684 1/20 0.68
HTR1A P08908 1/20 0.68
PDE6A P16499 1/20 0.68
PDE6G P18545 1/20 0.68
PDE4A P27815 1/20 0.68
ADORA2A P29274 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30199753 1.00 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL29357402 0.95 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL2693448 0.95 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL7959160 0.94 PDE5A (0.77) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL28482244 0.94 PDE5A (0.83) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL7964961 0.94 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL28417929 0.93 PDE5A (0.82) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL7920627 0.93 PDE5A (0.82) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL7965731 0.93 PDE5A (0.84) PDE5APDE6CPDE3BPDE3APDE1A
SCHEMBL147337 0.92 PDE5A (1.00) PDE5APDE6CPDE3BPDE3APDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111732593-A Piperazine oxide derivative and composition, preparation method and application thereof 黄泳华 2020-10-02 CN claimed
US-20230041334-A1 METHODS AND COMPOSITIONS FOR SMOKING CESSATION BEHAVIORAL DIAGNOSTICS, LLC (US) 2023-02-09 US disclosed
CN-111732593-A Piperazine oxide derivative and composition, preparation method and application thereof 黄泳华 2020-10-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041334-A1 METHODS AND COMPOSITIONS FOR SMOKING CESSATION PDE5A, PDE3A, PDE2A PDE5A 1/4885PDE6C 15/4885PDE3B 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.